RxDoctor Payments Data

Kehinde Ayeni, MD

Psychiatry · Detroit, MINPI 1366520470

Payments from drug & device makers

$291in general payments, 2019–2025

Across 14 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Luye Pharma (USA) Ltd.$71
  • Otsuka America Pharmaceutical, Inc.$70
  • Alkermes, Inc.$59
  • Johnson & Johnson$29
  • Indivior Inc.$18
  • Neurocrine Biosciences, Inc.$17
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$291100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$291 in reported general payments places this provider in the 55th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$43,916
Medicare patients
130
Services billed
452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate12$93,702
Abilify MaintenaAripiprazole29$82,004
Invega SustennaPaliperidone Palmitate15$48,828
AristadaAripiprazole Lauroxil15$39,913
LybalviOlanzapine/Samidorphan Malate23$39,170
Lurasidone Hcl47$22,547
TrintellixVortioxetine Hydrobromide19$9,402
Clozapine148$7,302
Quetiapine Fumarate ErQuetiapine Fumarate76$5,873
Paliperidone ErPaliperidone37$5,216
Adderall XrDextroamphetamine/Amphetamine12$4,824
Haloperidol Decanoate79$3,637
Quetiapine Fumarate349$3,215
Haloperidol108$3,046
Olanzapine OdtOlanzapine29$2,551

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$17$93,70212 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$70$82,00429 claims
Alkermes, Inc.Aristada, Lybalvi$59$79,08238 claims
Johnson & JohnsonInvega Sustenna$29$48,82815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →